TKPHF
Price
$29.45
Change
+$0.89 (+3.12%)
Updated
Aug 13 closing price
Capitalization
47.31B
TSMRF
Price
$23.74
Change
-$4.41 (-15.67%)
Updated
Jun 27 closing price
Capitalization
1.8B
Interact to see
Advertisement

TKPHF vs TSMRF

Header iconTKPHF vs TSMRF Comparison
Open Charts TKPHF vs TSMRFBanner chart's image
Takeda Pharmaceutical
Price$29.45
Change+$0.89 (+3.12%)
Volume$1.33K
Capitalization47.31B
Tsumura & Co
Price$23.74
Change-$4.41 (-15.67%)
Volume$100
Capitalization1.8B
TKPHF vs TSMRF Comparison Chart in %
Loading...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TKPHF vs. TSMRF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TKPHF is a StrongBuy and TSMRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (TKPHF: $29.45 vs. TSMRF: $23.74)
Brand notoriety: TKPHF and TSMRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TKPHF: 2% vs. TSMRF: 100%
Market capitalization -- TKPHF: $47.31B vs. TSMRF: $1.8B
TKPHF [@Pharmaceuticals: Generic] is valued at $47.31B. TSMRF’s [@Pharmaceuticals: Generic] market capitalization is $1.8B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TKPHF’s FA Score shows that 2 FA rating(s) are green whileTSMRF’s FA Score has 2 green FA rating(s).

  • TKPHF’s FA Score: 2 green, 3 red.
  • TSMRF’s FA Score: 2 green, 3 red.
According to our system of comparison, TKPHF is a better buy in the long-term than TSMRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TKPHF’s TA Score shows that 7 TA indicator(s) are bullish while TSMRF’s TA Score has 2 bullish TA indicator(s).

  • TKPHF’s TA Score: 7 bullish, 3 bearish.
  • TSMRF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, TKPHF is a better buy in the short-term than TSMRF.

Price Growth

TKPHF (@Pharmaceuticals: Generic) experienced а +3.11% price change this week, while TSMRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.3B) has a higher market cap than TSMRF($1.8B). TKPHF has higher P/E ratio than TSMRF: TKPHF (50.67) vs TSMRF (8.18). TKPHF YTD gains are higher at: 10.093 vs. TSMRF (-15.672). TKPHF has higher annual earnings (EBITDA): 1.13T vs. TSMRF (47.8B). TKPHF has more cash in the bank: 419B vs. TSMRF (82.4B). TSMRF has less debt than TKPHF: TSMRF (71.4B) vs TKPHF (4.51T). TKPHF has higher revenues than TSMRF: TKPHF (4.48T) vs TSMRF (165B).
TKPHFTSMRFTKPHF / TSMRF
Capitalization47.3B1.8B2,626%
EBITDA1.13T47.8B2,354%
Gain YTD10.093-15.672-64%
P/E Ratio50.678.18620%
Revenue4.48T165B2,715%
Total Cash419B82.4B508%
Total Debt4.51T71.4B6,311%
FUNDAMENTALS RATINGS
TKPHF vs TSMRF: Fundamental Ratings
TKPHF
TSMRF
OUTLOOK RATING
1..100
2742
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8731
PRICE GROWTH RATING
1..100
4778
P/E GROWTH RATING
1..100
2890
SEASONALITY SCORE
1..100
5030

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (5) in the null industry is in the same range as TSMRF (7). This means that TKPHF’s stock grew similarly to TSMRF’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as TSMRF (100). This means that TKPHF’s stock grew similarly to TSMRF’s over the last 12 months.

TSMRF's SMR Rating (31) in the null industry is somewhat better than the same rating for TKPHF (87). This means that TSMRF’s stock grew somewhat faster than TKPHF’s over the last 12 months.

TKPHF's Price Growth Rating (47) in the null industry is in the same range as TSMRF (78). This means that TKPHF’s stock grew similarly to TSMRF’s over the last 12 months.

TKPHF's P/E Growth Rating (28) in the null industry is somewhat better than the same rating for TSMRF (90). This means that TKPHF’s stock grew somewhat faster than TSMRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TKPHFTSMRF
RSI
ODDS (%)
Bullish Trend 1 day ago
39%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
46%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 4 days ago
10%
MACD
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
17%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
46%
Bullish Trend 1 day ago
13%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
42%
Bullish Trend 1 day ago
12%
Advances
ODDS (%)
Bullish Trend 17 days ago
40%
N/A
Declines
ODDS (%)
Bearish Trend 20 days ago
43%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
46%
Bearish Trend 1 day ago
12%
View a ticker or compare two or three
Interact to see
Advertisement
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESEA59.753.72
+6.64%
Euroseas Ltd
EVCM10.820.28
+2.66%
EverCommerce
ERJ57.52-2.26
-3.78%
Embraer SA
DTI2.00-0.10
-4.76%
Drilling Tools International Corp
PRFX1.35-0.07
-4.93%
PainReform Ltd

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TAK - TKPHF
27%
Poorly correlated
+1.35%
TEVJF - TKPHF
17%
Poorly correlated
N/A
ZTS - TKPHF
16%
Poorly correlated
+0.69%
BHC - TKPHF
15%
Poorly correlated
+11.05%
QNTM - TKPHF
13%
Poorly correlated
+0.45%
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and INNPF have been poorly correlated (+-0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and INNPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
INNPF - TSMRF
-0%
Poorly correlated
-99.14%
TKPHF - TSMRF
-0%
Poorly correlated
N/A
TCNNF - TSMRF
-1%
Poorly correlated
-7.35%
TEVJF - TSMRF
-1%
Poorly correlated
N/A
VEXTF - TSMRF
-4%
Poorly correlated
+2.72%
More